Home > Dermatology > SPIN 2022 > IMIDs in Adults and Children: New Developments > Men on biologics report fewer adverse events than women

Men on biologics report fewer adverse events than women

Presented By
Ms Jette van Lint , Pharmacovigilance Centre Lareb, the Netherlands
SPIN 2022
Results from Dutch pharmacovigilance data on biologic treatment showed a significant difference in the frequency of adverse drug reactions (ADR) in men and women. Interestingly, this did not lead to a discrepancy in patient-reported disease burden among the 2 groups. “In general, we know that women experience more ADRs, and these more often lead to hospitalisation than in men,” Ms Jette van Lint (Pharmacovigilance Centre Lareb, the Netherlands) stated [1]. Around 5% of unplanned hospital admissions are caused by ADRs [2]. Factors contributing to this difference in ADR reporting by men and women may include hormones, pharmacokinetics and pharmacodynamics, besides behavioural variance and social roles [1,3]. “We aimed to investigate differences in nature, frequency, and burden of patient-reported ADRs of biologics,” Ms van Lint explained. The prospective cohort study analysed monitoring data on patients treated with biologics for an immune-mediated in...

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on